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ABSTRACT 
When an egg is fertilized, before the new embryo can begin to 
develop, the egg must be “activated.”  The process of activation triggers 
the egg to complete meiosis, to begin translating new proteins, to degrade 
proteins and RNAs that are no longer required, and to modify its 
membranes to form a harder outer covering.  The universal signaling event 
is an increase in calcium levels that occurs in the egg at this time.  In many 
cell types, calcium causes changes through a conserved signaling pathway 
by binding to a protein called calmodulin, which in turn regulates the 
activities of other proteins.   
Calcineurin, a phosphatase, is one of those other proteins.  It has 
been proven experimentally that calcineurin plays a critical role in 
regulating egg activation in fruit flies and in frogs.  For example, 
Drosophila females expressing a constitutively active calcineurin (cnA-
act) in their germline are sterile.  To identify the proteins in the pathway 
by which calcineurin regulates egg activation, the Toshiro Aigaki lab 
tested whether there were Drosophila genes that interact genetically with 
calcineurin mutations. To do this, they searched for chromosomal regions 
whose deletion suppresses the sterility of cnA-act female flies.  Fourteen 
large chromosomal regions were identified.   
To define the precise gene(s) within each region that suppresses 
the sterility of cnA-act females, I have tested smaller deletions, and then 
individual mutations, within the five regions I am examining for 
interaction with cnA-act.  For three of the deletions, I have identified 
genes whose mutants significantly restore fertility of cnA-act females, and 
thus is a candidate to act within the calcineurin pathway.  The first is 
CG6927, a gene that is expressed in the ovary but currently has no known 
function.  The second is eIF3-S8, a transcription initiation factor.  The 
third is RpS24, a ribosomal protein.  The fourth is CG42565, which like 
CG6927, has no known function.  In the other two regions, I have 
narrowed down the cnA-act interacting genes to a small number of 
candidates, instead of the hundreds of genes within the original large 
region. I am currently testing the remaining candidates. 
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INTRODUCTION 
EGG ACTIVATION 
Egg activation is the transition of an egg from a mature oocyte to a state that can 
undertake embryo development.  During egg activation, several key processes occur: the 
eggshell is modified to prevent polyspermy and to protect the future embryo, meiosis 
resumes and completes, translation of new proteins initiates from stored maternal 
mRNAs, while other maternal mRNAs are degraded, and several proteins get 
dephosphorylated (Horner & Wolfner, 2008a; Figure 1).  In addition, the localization of 
certain mRNAs changes during this time (Weil et al., 2008).  In fruit flies, egg activation 
is triggered by mechanical stimulation of the egg during ovulation.  Fertilization is not 
required for activation (Heifetz et al., 2001; Horner & Wolfner, 2008b).  Drosophila eggs 
can be activated mechanically, but they only complete meiosis and then stop developing 
because haploid zygotes are inviable (Doane, 1960).  Prior to activation, Drosophila eggs 
are arrested in metaphase I of meiosis (King, 1970).  It remains in this dormant state until 
it is released by egg activation. 
 
CALCIUM SIGNAL TRANSDUCTION PATHWAY 
Currently, the key fact known about the egg activation cell signal pathway is that 
there is a surge of calcium ions that activates a protein known as calmodulin (Klee et al, 
1998).  This surge of calcium is conserved in vertebrates and marine invertebrates 
(Stricker, 1999).  Genetic and physiological evidence suggests that this calcium surge is 
conserved in Drosophila also (Horner et al., 2006; Horner & Wolfner, 2008a).  The likely 
target of the increased calcium, calmodulin, positively regulates two downstream 
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proteins: calmodulin-dependent kinase II (CaMKII) and the phosphatase, calcineurin 
(Figure 1).  In Xenopus laevis, upon activation, the influx of calcium triggers the release 
of the egg from meiotic arrest through the action of CaMKII (Liu & Maller, 2005).  
CaMKII phosphorylates ERP1, marking it for ubiquitination and subsequent degradation 
(Mochida & Hunt, 2007).   This allows the resumption of the cell cycle since ERP1 is an 
inhibitor of the anaphase promoting complex/cyclosome (APC/C) so it maintains the egg 
in the arrested state prior to degradation (Rauh et al., 2005; Reber et al., 2008).  
Mutations in the γ isoform of CaMKII in mice cause female sterility since the eggs 
remain arrested and are never able to become activated (Backs et al., 2010).   
Calcineurin was found to be activated by calmodulin during egg activation in 
Xenopus laevis (Nishiyama et al, 2007).  The rise in intracellular calcium leads to the 
transient activation of calcineurin by the calcium-dependent calmodulin (Nishiyama et 
al., 2007).  Calcineurin activation must then be inhibited in order for the cell to continue 
meiosis from where it had been arrested.  This was proven by the fact that maintaining a 
high level of calcineurin after activation prevents the “growth of sperm asters” and 
hinders the “migration of male and female pronuclei towards each other . . . in fertilized 
eggs” (Nishiyama et al., 2007).  Therefore, calcineurin must be properly regulated in 
order for continued embryonic development after fertilization.  In 2006, Horner et al. and 
Takeo et al. found that mutations in sarah (sra), which encodes calcipressin, a regulator 
of calcineurin activity, result in female sterility due to failure of eggs to activate. 
Therefore, calcineurin is clearly an important component of the egg activation pathway, 
yet its actual role and specific gene targets remain unknown. 
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To further study the role of calcineurin, Toshiro Aigaki’s lab created a 
constitutively active calcineurin (cnA-act) Drosophila mutant and generated fly lines in 
which this was expressed.  These flies produced a form of calcineurin that is truncated at 
the catalytic C-terminus, preventing the regulatory subunit from being able to bind and 
inhibit the phosphatase activity.  Females expressing cnA-act were sterile, with laying 
eggs that remained arrested in meiosis, suggesting that constitutive (rather than transient) 
activation of calcineurin interfered with egg activation (Takeo et al., 2010).  Takeo et al. 
further found that certain deletions, when present heterozygously in cnA-act flies, 
counteract the effect of cnA-act, and restore fertility (Takeo et al., 2006; T. Aigaki, 
personal communication; Figure 2).  I hypothesize that these deletions restored fertility 
by each removing a gene coding for a protein that interacts with calcineurin in the egg 
activation pathway.  In deletion heterozygotes, only half the normal amount of their 
protein would be made due to the decreased gene dosage.  If the protein were one through 
which calcineurin caused egg activation, lower doses of it should counter the effects of 
increased calcineurin.  For example, lower levels of a protein with a similar function 
could mean that the excess calcineurin could take over its role and restore normal 
development.  Another possibility is that, in the heterozygous mutants, there are lower 
levels of the protein of interest so the fact that calcineurin is constantly positively 
regulating it would not matter because there is only so much that can get activated 
regardless of how much active calcineurin is present.  Finally, lower levels of this protein 
could release another protein from either being sequestered or inactivated so it can 
interact with calcineurin to inhibit its activity and restore normal levels. 
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RELEVANCE 
This research is relevant scientifically and has potential to be of relevance to 
medical diagnostics.  First, it will reveal a great deal about the calcineurin pathway, a 
conserved pathway in all organisms tested, and one that appears to be conserved for a 
role in activation.  Despite its importance, many molecules that calcineurin regulates to 
cause egg activation are still unknown in all systems.  The genetics method just described 
can provide a way to find these downstream molecules so that their actions and 
interactions can be studied. 
 Diagnostically, this research may become applicable in the future because the egg 
activation pathway in Drosophila is a model for that in mammals – even humans.  
Though the initial signal differs (sperm entry in mammals including humans, 
mechanosensitive triggers in Drosophila), the events triggered by the signal appear to be 
common to all.  It is possible that some women may struggle with infertility due to the 
fact that the egg gets fertilized by the sperm but, for some unknown reason, does not 
continue to develop.  If the proteins involved with egg activation can be identified and the 
pathway elucidated in a model organism like Drosophila, more can be understood about 
the mechanism in humans as well.  This knowledge could, therefore, be applied in the 
future to designing diagnostic tests and possibly treatments for infertility in women.     
 
OBJECTIVE 
 The overall purpose of my project was to define the precise gene(s) within each 
region identified that suppresses the sterility of cnA-act female and, therefore, act(s) 
within the calcium-triggered signal transduction pathway.  The overall method was to 
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cross flies, so as to generate females carrying cnA-act and heterozygous for a mutant 
allele for each single gene uncovered by an interacting deficiency.  The number of 
progeny produced by these females was compared to the number produced by cnA-act 
females.    Genes of interest were ones whose mutant suppressed cnA-act and thus, 
resulted in higher fertility than the near-sterility of cnA-act females. 
 
MATERIALS AND METHODS 
FLY CULTURE 
 Fly stocks were raised on yeast-glucose-agar medium at 22.5± 2°C in a 12-h 
L:12-h D photoperiod. The wild-type used was the P2 strain of Oregon R (ORP2) (Allis 
et. al., 1977).  The mutant stocks of genes of interest that were available were obtained 
from the Bloomington Drosophila Stock Center at the Department of Biology of Indiana 
University.  Stocks were transferred to new vials every week to ensure optimal growth 
and to prevent propagation of mites. 
 
GENETIC CROSS SCHEME 
 In order to examine the interaction between a gene of interest and calcineurin, it 
was necessary to obtain flies that carry both the cnA-act transgene construct with a 
truncated form of the C-terminal part of the protein and a P-element insertion in the gene 
of interest.  Truncating the C-terminus, or catalytic subunit, prevents binding of the 
regulatory subunit, thereby rendering the protein constitutively active.  To acquire these 
flies, Drosophila virgin females with mutations in individual genes of interest were 
crossed with males carrying cnA-act, driven in the germline by a nanos (nos) driver, over 
7 
 
a balancer (Figure 3). The Aigaki lab gave us a balanced stock of cnA-act/TM3 flies for 
the purpose of this experiment (Takeo et al., 2006). The balancer used contained the 
markers Stubble and Serrated.  Since heterozygous cnA-Act females are sterile, the cnA-
act males must be regenerated with a new cross each generation.  To do this, w[1118] 
females that carry the TM3 (Sb, Ser) balancer must be crossed to the cnA-Act balanced 
males.  The cnA-Act/TM3 males generated from this cross are then crossed to females 
carrying a P-element insertion in the gene of interest (from a homozygous stock or from a 
balanced stock if the mutation was homozygous lethal; Figure 3).  From the progeny, I 
collected non-Stubble, non-Serrated flies, which have constitutively active calcineurin 
and contain one copy of the mutant allele in the gene of interest.  The control cnA-Act 
females used were from the cross that is used to regenerate the cnA-Act/TM3 stock.   
 
FERTILITY/FECUNDITY ASSAY  
 Experimental and control females were aged, as virgins, for 3-5 days with yeast 
and were then mated to wild-type (ORP2) males.  Typically, 8-10 females were used per 
gene of interest (in some cases, fewer were used due to fitness of strain).  After mating, 
the male was removed from the vial to prevent remating.  After 24 hours, the females 
were transferred to new vials and the eggs they had laid in the first vial were counted.  
This was repeated for a total of five days.  After two weeks, the progeny from each vial 
were counted.  The hatchability ratio was calculated by dividing the number of progeny 
eclosed from a given vial by the total number of eggs that had been laid in that vial.  I ran 
a Wilcoxon Test between the hatchability ratios of females carrying both the mutation of 
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interest and the cnA-act construct and those of females with just the cnA-act construct.  P-
values < 0.01 were considered significant.   
 
RESULTS 
Fertility/fecundity assays were used to analyze the potential interaction between 
calcineurin and candidates for the calcium-dependent egg activation pathway.  This was 
done by crossing virgin females that are mutant for a candidate gene to cnA-act males 
(Figure 3).  Genes were examined within several deletions that had been found to 
suppress sterility in a screen by the Aigaki lab.   
The first deletion I examined, Df(1)JC70, is located on the X chromosome and 
was found to restore fertility of cnA-act females to 70.6%, meaning that 70.6% percent of 
eggs laid develop into adult flies (T. Aigaki, personal communication).  I was able to 
reproduce this suppression of sterility result as well.  I found that Df(1)JC70 restored 
fertility of cnA-act females to an average of 82.0% (Figure 4).  This deletion’s high level 
of suppression and the fact that there were fewer candidate genes under it to screen gave 
me a greater chance of finding a gene that interacts in the calcineurin pathway.  Since 
calcineurin is a phosphatase, it was initially believed that a deletion could have restored 
fertility by having removed a gene that coded for another phosphatase, a kinase or kinase 
binding protein, etc.  Therefore, I first tested individual mutants with P-element insertions 
in genes coding for either kinases, phosphatases, or kinase-binding proteins uncovered by 
Df(1)JC70.  None of the genes that I tested restored fertility to cnA-act females.  As a 
result, 29 genes were eliminated as possible components of the egg activation signal 
transduction pathway, as there was no significant increase in hatchability ratios of virgin 
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females containing both a mutation in the gene of interest and the cnA-act construct 
compared with that of virgin females with only the cnA-act construct. Therefore, they 
will not be further discussed (Table 1).  One gene, CG6927, was found to significantly 
suppress sterility when compared to cnA-act control females (P<0.0001; Figure 5).   
 Other deficiencies found in the Aigaki screen to suppress sterility of cnA-act 
females span many more genes than Df(1)JC70.  Therefore, to narrow down the number 
of candidate genes, I performed fertility/fecundity assays on smaller deletions within each 
of 4 of the larger ones (Table 2).  I did this by crossing females carrying the deficiency 
chromosome over a balancer with males carrying the constitutively active calcineurin.  If 
the daughter flies carrying the deficiency and cnA-act were as sterile as when they carried 
just cnA-act alone, I was able to eliminate that chromosomal region since it did not 
contain a gene that interacts with calcineurin.  If sterility was suppressed in the daughters, 
I proceeded to test genes within that smaller deficiency.  This enabled me to eliminate 
hundreds of genes under each larger deficiency, leaving me with approximately 10 to test 
for each one (Figure 6). 
 Deficiency Df(2R)14H10Y-53 on the second chromosome was found to restore 
fertility to 45.9% (T. Aigaki, personal communication).  After testing the smaller 
deficiencies, Df(2R)Exel7149 and Df(2R)BSC347 were both found to significantly 
suppress sterility (P=0.0002, P=0.0012; Figure 7; Table 2).  The region where these two 
deletions overlap contains 11 genes and was considered to be the likely location of the 
candidate gene (Figure 6).  Out of these 11 genes, eIF3-S8 was found to significantly 
restore fertility of cnA-act females (P=0.0013) (Figure 8).  The other 10 were not found 
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to significantly suppress sterility or significantly enhanced it, so they will not be 
discussed further (Table 1). 
 Deficiency Df(2R)X58-12, also on the second chromosome, was found to restore 
fertility to 19.4% (T. Aigaki, personal communication).  After screening smaller 
deficiencies within it, Df(2R)Exel7173 and Df(2R)BSC598 were found to significantly 
suppress sterility (P=0.009, P=0.0104; Figure 9; Table 2).  However, Df(2R)Exel7173 is 
found within the slightly larger deletion Df(2R)BSC597, which showed no significant 
suppression (P=0.1046; Figure 9).  Therefore, genes were not examined under this region.  
Overall, I narrowed down a region of 22 gene candidates under Df(2R)BSC598, 12 of 
which had mutant stocks available to be ordered.  So far, 9 have been tested and 2 have 
been found to be potential candidate genes.  Preliminary data from RpS24 suggests that it 
significantly restores fertility of cnA-act females (P=0.0078; Figure 10).  However, only 
3 females were used for this fertility/fecundity test so additional tests must be done to 
confirm this result.  CG42565 was also found to suppress sterility (P<0.0001; Figure 11).  
The other 7 either did not suppress sterility or significantly enhanced it, so they will not 
be discussed further (Table 1). 
 For Df(3L)AC1, the smaller deletions Df(3L)BSC390, Df(3L)BSC393, 
Df(3L)BSC576, and Df(3L)BSC283 were all found either to not suppress or to enhance 
the sterility phenotype (Figure 12; Table 2).  However, there are still two smaller 
deletions that need to be tested in order to narrow down the region of candidate genes 
even further.  Similarly, for Df(2R)stan1, the smaller deletions Df(2R)BSC281, 
Df(2R)ED2098, and Df(2R)BSC336 all showed either no suppression or an enhancement 
of the sterility phenotype (Figure 13; Table 2).  Df(2R)BSC231 showed near-significant 
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suppression (P=0.020; Figure 13).  However, there is still another smaller deletion that 
needs to be tested so genes under Df(2R)stan1 have not yet been examined more closely. 
 
DISCUSSION 
The intricacies of the egg activation pathway are complex and elusive.  This is 
due to the fact that it is such a rapid process that involves a vast number of changes 
within the egg.  To dissect this pathway, I studied the genetic interactions between 
calcineurin and certain genes of interest that were uncovered by deletions known to 
suppress sterility in cnA-act flies.  Genes whose heterozygous P-element insertions 
resulted in significantly increased hatchability of cnA-act progeny in a fertility/fecundity 
assay were determined to be candidate genes for the egg activation pathway.  As stated 
previously, it was initially believed that the most likely candidate gene would be another 
phosphatase, a kinase or kinase binding protein.  However, after performing 
fertility/fecundity assays on genes of this category under the first deficiency, Df(1)JC70, 
none of the ones tested were found to restore fertility to similar levels, so the rest of the 
genes under this deficiency were examined (Table 2). 
 
CG6927 
Mutant alleles of CG6927, a gene that is found under Df(1)JC70, showed the 
strongest suppression of cnA-act sterility.  This gene currently has no known function and 
has not yet been studied in Drosophila.  The sequence suggests that it may function as a 
gated ion channel (but the only evidence for this is sequence or structure similarity with 
other proteins involved with ion transfer; FlyBase).  CG6927 mutant heterozygosity 
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restored fertility of cnA-act females to nearly 100%, which is much higher than that seen 
for Df(1)JC70 (Figure 4).  This difference between the hatchability ratio for CG6927 
mutants and flies carrying Df(1)JC70 could be due to the fact that haplo-insufficiency of 
other genes deleted by the deficiency somehow lowers the fertility of the female at the 
same time that haplo-insufficiency for CG6927 raises it.  Consistent with this idea, eggs 
of the cnA-act females have an average hatchability of 0.06.  However, in many of the 
fertility/fecundity assays, eggs from the heterozygous mutants showed an enhanced 
sterility phenotype with a decrease in hatchability to nearly 0 (Figure 4).  This could 
explain the difference between the hatchability values since there could be genes under 
the deficiency that actually enhance the sterility phenotype, which counteracts the 
sterility suppression of CG6927.   
 
EIF3-S8 
eIF3-S8 was found to be one gene under Df(2R)14H10Y-53  whose mutant alleles 
suppressed the sterility of cnA-act.  Based on sequence and structural similarity, this gene 
likely encodes a translation initiation factor (Flybase).  Since there is a shift in which 
mRNAs get translated and which get degraded at egg activation (Tadros et al., 2003), it 
was exciting to find a translation factor as a possible downstream target of the egg 
activation signal.  Translation initiation factors can be regulated by covalent modification 
via the addition or removal of a phosphate group (Morley & Pain, 1995).  My results 
suggest that eIF3-S8 may be downstream of calcineurin in the egg activation pathway, 
perhaps providing a link between the calcium signal for activation and translational 
control. 
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RPS24 AND CG42565 
Mutations in two genes under Df(2R)X58-12, RpS24 and CG42565, independently 
suppressed cnA-act sterility.  Like eIF3-S8, RpS24 is involved in translation, although 
additional experiments need to be performed in order to confirm its exact role (FlyBase; 
Brogna et al., 2002).  However, since only 3 females were tested, the fertility/fecundity 
assay for this mutant, while encouraging (Figure 10) is very preliminary, and must be 
repeated with a larger sample size. CG42565 has no known function in Drosophila and 
has not been examined for sequence or structural similarity.  However, mutants in this 
gene significantly suppressed sterility of cnA-act females so it is a likely candidate gene 
for the egg activation pathway (P<0.0001; Figure 11).  If results are reproducible for both 
genes, they should be examined in greater depth in order to determine the genes’ precise 
roles in egg activation.  
 
CONCLUSION AND FUTURE DIRECTIONS 
These results confirm that CG6927, eIF3-S8, CG42565, and perhaps RpS24 are 
candidates for involvement in the egg activation pathway due to their genetic interaction 
with calcineurin and 46 genes can be eliminated as candidates, including a number of 
phosphatases, kinases, and kinase-binding proteins.  However, more study is needed to 
determine the other components of the pathway that are located within the additional 
deletions reported to suppress sterility.  In addition, these candidate proteins must be 
examined for their exact roles and locations within the pathway and their specific effects 
during egg activation. To do so, it would be helpful to look at whether or not candidate 
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gene mutation homozygotes have any problems with egg activation or fertility in general 
(if they are not homozygous lethal).   
In the future, it needs to be confirmed that all of these (especially the translation 
factor) do, in fact, interact with calcineurin and are not merely affecting the transgene 
construct that results in the constitutive calcineurin activity (Takeo et al., 2006).  This can 
be tested by RT-PCR and Western blot.  RpS24 and CG42565 must also be examined 
more closely to ensure that the result was not due to a limited sample size but is a true 
effect. 
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Table 1.  Candidate genes tested.  * denotes those whose mutants actually showed 
significant enhancement of the sterility phenotype.  These genes were not examined 
further. ** denotes genes whose mutants significantly suppressed the sterility phenotype. 
 
Deletion Gene Position n Hatchability P-value 
Df(1)JC70 CG3009 4C11-4C11 9 0.108 0.086 
 rap 4C11-4C12 9 0.005 0.006* 
 Pp2C1 4C12-4C13 7 0.067 0.182 
 ctp 4C13-4C14 10 0.001 0.002* 
 CG7010 4C14-4C14 7 0.124 0.135 
 CG7024 4C14-4C14 10 0.001 0.018* 
 CG6986 4C14-4C15 8 0.000 0.002* 
 CG2861 4D1-4D2 10 0.000 0.001* 
 CG6927 4D4-4D5 23 0.924 <0.0001** 
 CG32772 4D5-4D5 10 0.048 0.612 
 CG42594 4D5-4D5 10 0.005 0.219 
 CG6903 4D6-4D6 8 0.044 0.627 
 CG4068 4D6-4D7 12 0.118 0.883 
 Ptp4E 4D7-4D7 6 0.013 0.128 
 CG32767 4E2-4E2 8 0.018 0.193 
 ovo 4E2-4E2 9 0.038 0.257 
 rg 4E2-4F3 7 0.000 0.004* 
 cdk7 4F4-4F4 3 0.005 0.130 
 CanB 4F5-4F5 8 0.079 0.154 
 sans fille 4F4-4F4 17 0.104 0.366 
 CG4198 4F4-4F5 10 0.032 0.336 
 XRCC1 4F5-4F5 8 0.016 0.230 
 CG15930 4F5-4F5 10 0.003 0.003* 
 sk 4F5-4F9 10 0.000 0.002* 
 NAAT1 4F9-4F9 9 0.000 0.001* 
 yu 4F9-4F10 6 0.059 0.581 
 CG15784 4F10-4F10 10 0.053 0.709 
 CG4165 4F10-4F10 10 0.001 0.037* 
 CG12730 5A2-5A2 15 0.093 0.695 
 Vsx2 5A3-5A5 7 0.000 0.007* 
Df(2R)14H10Y-53 CG10936 54D1-54D2 8 0.079 0.678 
 rhi 54D2-54D2 7 0.025 0.283 
 CG18186 54D2-54D2 8 0.000 0.003* 
 CG30106 54D3-54D3 9 0.037 0.351 
 eIF3-S8 54D4-54D4 10 0.187 0.007** 
 CG30108 54D4-54D4 8 0.042 1.000 
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 CG30109 54D4-54D4 8 0.081 0.116 
 CG6459 54D4-54D4 6 0.049 0.707 
 sema-1B 54D4-54D5 10 0.005 0.098 
 HPS4 54D5-54D5 10 0.061 0.367 
 swi2 54D5-54D6 10 0.093 0.345 
Df(2R)X58-12 CG3927 58F1-58F1 12 0.022 0.086 
 CG34445 58F3-58F3 10 0.091 0.384 
 RpS24 58F3-58F3 3 0.630 <0.0001** 
 Ugt58Fa 58F3-58F3 9 0.021 0.134 
 CG2852 58F3-58F3 9 0.119 0.490 
 CG13510 58F4-58F4 9 0.013 0.044* 
 CG42565 58F4-58F4 11 0.630 <0.0001** 
 CG42566 58F4-58F4 10 0.005 0.006* 
 CG3746 58F4-58F4 11 0.006 0.008* 
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Table 2.  Smaller deletions within larger ones tested  * denotes those that actually 
showed significant enhancement of the sterility phenotype.  These regions were not 
examined further. ** denotes regions that significantly suppressed the sterility phenotype. 
 
Deletion Sub Deletion n Hatchability P-value 
Df(2R)14H10Y-53 Df(2R)Exel7149 8 0.644 0.0002** 
 Df(2R)BSC347 9 0.524 0.0012** 
 Df(2R)BSC348 10 0.024 0.4474 
Df(2R)X58-12 Df(2R)BSC597 9 0.024 0.1046 
 Df(2R)Exel7171 10 0.036 0.8237 
 Df(2R)Exel7173 10 0.145 0.009** 
 Df(2R)BSC598 10 0.182 0.0104** 
Df(3L)AC1 Df(3L)BSC390 10 0.002 0.0127* 
 Df(3L)BSC393 8 0.002 0.0148* 
 Df(3L)BSC576 10 0.002 0.0076* 
 Df(3L)BSC283 9 0.094 0.4474 
Df(2R)stan1 Df(2R)BSC281 10 0.074 0.5281 
 Df(2R)ED2098 6 0 0.0223* 
 Df(2R)BSC336 9 0.028 0.5694 
 Df(2R)BSC231 10 0.14 0.0196** 
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Figure 1.  Egg activation pathway.  A surge of calcium ions activates calmodulin which 
in turn activates calcineurin and CaMKII.  This sets off a signal cascade that eventually 
leads to the key processes in egg activation (Horner & Wolfner, 2008a). 
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Figure 2.  Each strip represents a part of the Drosophila genome.  Bars above represent 
deletions tested by the Aigaki lab.  Bars filled in red are deletions found to suppress 
sterility.  Deletions 1, 9, 12, 14, 16 correspond to Df(1)JC70, Df(2R)stan1, 
Df(2R)14H10Y-53 , Df(2R)X58-12, and Df(3L)AC1 and are the deletions examined in this 
paper (T. Aigaki, personal communication). 
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Figure 3.  Cross scheme to acquire flies carrying both the C-terminal truncated form of 
cnA-act driven in the germline by nos and a mutation for the gene to be tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
♂    +   ; nos>cnA-act  x  Candidate gene mutant;    +    ♀       
        Y          Sb Ser                      Sb Ser                 + 
Candidate gene mutant ;       +           ♀       
                  +                 nos>cnA-act 
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Figure  4.  Fertility/fecundity assay for the first deletion: Df(1)JC70 (P=0.0002), and 
three genes under this deficiency – CG6903 (P=0.556), CG32772 (P=0.612), CG6927 
(P<0.0001).  CnA-act females were used for comparison.  For box plots, center line 
represents the median.  The line below designates the 1st quartile, and the line above is 
the 3rd quartile.  The whiskers correspond to +/- 1½ of the Interquartile Range (IQR).  
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cnA-act     Df(1)JC70     CG6903EY08878   CG32772KG04220a  CG6927 
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Figure 5. Fertility/fecundity assay for CG6927.  A mutation in CG6927 significantly 
suppressed sterility in cnA-act female flies (P<0.0001**).  For box plots, center line 
represents the median.  The line below designates the 1st quartile, and the line above is 
the 3rd quartile.  The whiskers correspond to +/- 1½ of the Interquartile Range (IQR). 
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Df(3L)AC1 – 50.6% restored fertility (T. Aigaki, personal communication) 
 
 
 
 
 
 
 
 
 
Df(2R)14H10Y-53 – 45.9% restored fertility (T. Aigaki, personal communication) 
 
 
 
 
 
 
 
 
 
Df(2R)stan1 – 29.2% restored fertility (T. Aigaki, personal communication) 
 
  
 
 
 
 
 
 
 
Df(2R)X58-12 – 19.4% restored fertility (T. Aigaki, personal communication) 
 
 
 
 
 
 
 
 
 
Figure 6.  Four deletions examined (not including Df(1)JC70).  Each deletion was 
broken up into smaller deletions that spanned the larger one.  Red x’s indicate regions 
that were ruled out.  Red boxes indicate regions that are likely to contain a candidate gene 
for the egg activation pathway. 
Df(2R)BSC597 Df(2R)BSC598 
Df(2R)Exel7171 Df(2R)Exel7173 
Df(2R)ED2098 Df(2R)Exel6060 
Df(2R)BSC231 Df(2R)BSC336 Df(2R)BSC281 
Df(2R)Exel7149 
Df(2R)BSC347 
Df(2R)BSC348 
Df(3L)BSC390 
 
Df(3L)BSC113 
Df(3L)BSC391 
Df(3L)BSC576 Df(3L)BSC283 
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Figure 7.  Df(2R)14H10Y-53 screen for smaller deletions: Df(2R)Exel7149 
(P=0.0002**), Df(2R)BSC347 (P=0.001**), Df(2R)BSC348 (P=0.447).  CnA-act females 
were tested for comparison.  For box plots, center line represents the median.  The line 
below designates the 1st quartile, and the line above is the 3rd quartile.  The whiskers 
correspond to +/- 1½ of the Interquartile Range (IQR). 
Treatment 
 cnA-act        Df(2R)Exel7149      Df(2R)BSC347    Df(2R)BSC348 
    + cnA-act                 + cnA-act           + cnA-act  
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Figure 8. Fertility/fecundity assay for eIF3-S8.  A mutation in eIF3-S8 significantly 
suppressed sterility in cnA-act female flies (P=0.0013**).  For box plots, center line 
represents the median.  The line below designates the 1st quartile, and the line above is 
the 3rd quartile.  The whiskers correspond to +/- 1½ of the Interquartile Range (IQR). 
 
     cnA-act              eIF3-S8EY07713+ cnA-act 
            n=9                                       n=10 
Treatment 
Av
g 
ha
tch
ab
ilit
y (
1.
0 
= 
10
0%
 h
at
ch
ab
ilit
y)
 
28 
 
 
 
Figure  9.  Df(2R)X58-12 screen for smaller deletions: Df(2R)BSC597 (P=0.105), 
Df(2R)Exel7171 (P=0.824), Df(2R)Exel7173 (P=0.009**), Df(2R)BSC598 (P=0.010**).  
CnA-act females were tested for comparison.  For box plots, center line represents the 
median.  The line below designates the 1st quartile, and the line above is the 3rd quartile.  
The whiskers correspond to +/- 1½ of the Interquartile Range (IQR). 
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Figure 10. Fertility/fecundity assay for RpS24.  A mutation in RpS24 significantly 
suppressed sterility in cnA-act female flies (P=0.008**).  CnA-act females were tested for 
comparison.  For box plots, center line represents the median.  The line below designates 
the 1st quartile, and the line above is the 3rd quartile.  The whiskers correspond to +/- 1½ 
of the Interquartile Range (IQR). 
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Figure 11. Fertility/fecundity assay for CG42565.  A mutation in CG42565 significantly 
suppressed sterility in cnA-act female flies (P<0.0001**).  CnA-act females were tested 
for comparison.  For box plots, center line represents the median.  The line below 
designates the 1st quartile, and the line above is the 3rd quartile.  The whiskers correspond 
to +/- 1½ of the Interquartile Range (IQR). 
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Figure 12.  Df(3L)AC1 screen for smaller deletions: Df(3L)BSC390 (P=0.0127 – lower 
hatchability), Df(3L)BSC393 (P=0.015 – lower hatchability), Df(3L)BSC576 (P=0.008 – 
lower hatchability), Df(3L)BSC283 (P=0.447).  CnA-act females were tested for 
comparison.  For box plots, center line represents the median.  The line below designates 
the 1st quartile, and the line above is the 3rd quartile.  The whiskers correspond to +/- 1½ 
of the Interquartile Range (IQR). 
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Figure 13.  Df(2R)stan1 screen for smaller deletions: Df(2R)BSC281 (P=0.528), 
Df(2R)ED2098 (P=0.022 – lower hatchability), Df(2R)BSC336 (P=0.569), 
Df(2R)BSC231 (P=0.020**).  CnA-act females were tested for comparison.  For box 
plots, center line represents the median.  The line below designates the 1st quartile, and 
the line above is the 3rd quartile.  The whiskers correspond to +/- 1½ of the Interquartile 
Range (IQR). 
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